Mylan NV (MYL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Mylan NV (MYL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011020
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, cardiovascular, central nervous systems, infectious disease, oncology, anesthesia and others. Mylan sells its products to retail pharmacy chains, wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies. The company has research and development facilities in the US, Canada, the UK, Ireland, Italy, Germany, India and Japan. Mylan is headquartered in Hatfield, Hertfordshire, the UK.

Mylan NV (MYL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mylan NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Mylan NV, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Mylan NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Mylan NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Mylan NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Mylan NV, Medical Equipment, Deal Details 11
Asset Purchase 11
Mylan Completes Acquisition Of Respiratory Delivery Platform From Pfizer For US$348 Million 11
Venture Financing 13
Zyomyx Raises US$6 Million In First Closing Of Series 2 Preferred Financing 13
Partnerships 14
UDL Labs Enters Into Licensing Agreement With Humeca 14
Mylan Enters Into Distribution Agreement With Zyomyx For CD4 T-Cell Count Test 15
Phosphagenics Enters Into Licensing Agreement With Agila Specialties For TPM Technology 17
Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 18
Debt Offering 19
Mylan Raises USD551.6 Million in Public Offering of Bonds Due 2020 19
Mylan Raises USD1 Billion in Private Placement of 5.25% Notes Due 2046 20
Mylan Raises USD2.25 Billion in Private Placement of 3.95% Notes Due 2026 21
Mylan Raises USD2.25 Billion in Private Placement of 3.15% Notes Due 2021 22
Mylan Raises USD1 Billion in Private Placement of 2.5% Notes Due 2019 23
Mylan NV – Key Competitors 24
Mylan NV – Key Employees 25
Mylan NV – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 33
Financial Announcements 33
Nov 06, 2017: Mylan Reports Third Quarter 2017 Results and Updates 2017 Guidance 33
Aug 09, 2017: Mylan Reports Second Quarter 2017 Results and Updates 2017 Guidance 35
May 10, 2017: Mylan Reports First Quarter 2017 Results 39
Mar 01, 2017: Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance 41
Nov 09, 2016: Mylan Reports Third Quarter 2016 Results 43
Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 47
Corporate Communications 50
Sep 13, 2017: Mylan Names Dennis Zeleny as Chief Human Relations Officer 50
May 01, 2017: Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors 51
Mar 28, 2017: Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer 52
Legal and Regulatory 53
Nov 10, 2017: Mylan Announces Voluntary Delisting from the Tel Aviv Stock Exchange 53
Oct 31, 2017: Mylan Provides Statement in Response to Announcement of Proposed Amendments to Civil Complaint 54
Product News 55
03/09/2016: TGA issues safety alert about EpiPen Adrenaline Auto-injector 55
Other Significant Developments 56
Mar 08, 2016: Mylan Health Hackathon to Focus on Delivering Better Health for a Better World 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Mylan NV, Medical Equipment, Key Facts, 2016 2
Mylan NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Mylan NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Mylan NV, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Mylan NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Mylan NV, Deals By Market, 2011 to YTD 2017 9
Mylan NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Mylan Completes Acquisition Of Respiratory Delivery Platform From Pfizer For US$348 Million 11
Zyomyx Raises US$6 Million In First Closing Of Series 2 Preferred Financing 13
UDL Labs Enters Into Licensing Agreement With Humeca 14
Mylan Enters Into Distribution Agreement With Zyomyx For CD4 T-Cell Count Test 15
Phosphagenics Enters Into Licensing Agreement With Agila Specialties For TPM Technology 17
Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 18
Mylan Raises USD551.6 Million in Public Offering of Bonds Due 2020 19
Mylan Raises USD1 Billion in Private Placement of 5.25% Notes Due 2046 20
Mylan Raises USD2.25 Billion in Private Placement of 3.95% Notes Due 2026 21
Mylan Raises USD2.25 Billion in Private Placement of 3.15% Notes Due 2021 22
Mylan Raises USD1 Billion in Private Placement of 2.5% Notes Due 2019 23
Mylan NV, Key Competitors 24
Mylan NV, Key Employees 25
Mylan NV, Other Locations 26
Mylan NV, Subsidiaries 27

★海外企業調査レポート[Mylan NV (MYL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Elecnor SA (ENO):電力:M&Aディール及び事業提携情報
    Summary Elecnor SA (Elecnor) is an engineering and construction company. It specializes in engineering, development and construction of projects relating to infrastructure, renewable energies and new technologies. The company focuses on end-to-end management of electricity, power generation, telecom …
  • Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets it …
  • LGT Group Foundation:企業の戦略・SWOT・財務情報
    LGT Group Foundation - Strategy, SWOT and Corporate Finance Report Summary LGT Group Foundation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oncor Electric Delivery Company LLC:電力:M&Aディール及び事業提携情報
    Summary Oncor Electric Delivery Company LLC (Oncor) a subsidiary of NextEra Energy, Inc., is a regulated electricity transmission and distribution company that operates distribution and transmission systems. It provides transmission grid connections to merchant generation facilities and interconnect …
  • Genesis Energy LP (GEL):企業の財務・戦略的SWOT分析
    Genesis Energy LP (GEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hyperion Insurance Group Ltd:企業の戦略・SWOT・財務情報
    Hyperion Insurance Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Hyperion Insurance Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Progenity Inc:医療機器:M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Crown Castle International Corp.:企業の戦略・SWOT・財務情報
    Crown Castle International Corp. - Strategy, SWOT and Corporate Finance Report Summary Crown Castle International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sonic Corp.:企業の戦略・SWOT・財務情報
    Sonic Corp. - Strategy, SWOT and Corporate Finance Report Summary Sonic Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Diamond Offshore Drilling Inc (DO):企業の財務・戦略的SWOT分析
    Diamond Offshore Drilling Inc (DO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Herantis Pharma Plc (HRTIS):医療機器:M&Aディール及び事業提携情報
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • Laboratorios SALVAT SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorios SALVAT SA (SALVAT) is a manufacturer of pharmaceutical products for healthcare industries. The company offers prescription and over-the- counter drugs in various segments such as personal healthcare, metabolism, urology, ophtholmology, dermatology and malaria. Its personal healt …
  • Marathon Oil Corporation:企業の戦略・SWOT・財務情報
    Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Meridian Bioscience Inc (VIVO):企業の財務・戦略的SWOT分析
    Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Volex plc (VLX):企業の財務・戦略的SWOT分析
    Volex plc (VLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Resolute Forest Products Inc (RFP):企業の財務・戦略的SWOT分析
    Resolute Forest Products Inc (RFP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Republic Airline, Inc.:企業の戦略・SWOT・財務情報
    Republic Airline, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Airline, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Teijin Ltd (3401):医療機器:M&Aディール及び事業提携情報
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • Enterprise Products Partners L.P.:企業の戦略・SWOT・財務情報
    Enterprise Products Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Enterprise Products Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆